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Abstract
Cannabis use is associated with known cardiovascular side effects such as cardiac arrhythmias or even sudden cardiac death. 
The mechanisms behind these adverse effects are unknown. The aim of the present work was to study the cellular cardiac 
electrophysiological effects of cannabidiol (CBD) on action potentials and several transmembrane potassium currents, such 
as the rapid  (IKr) and slow  (IKs) delayed rectifier, the transient outward  (Ito) and inward rectifier  (IK1) potassium currents 
in rabbit and dog cardiac preparations. CBD increased action potential duration (APD) significantly in both rabbit (from 
211.7 ± 11.2. to 224.6 ± 11.4 ms, n = 8) and dog (from 215.2 ± 9.0 to 231.7 ± 4.7 ms, n = 6) ventricular papillary muscle at 
5 µM concentration. CBD decreased  IKr,  IKs and  Ito (only in dog) significantly with corresponding estimated  EC50 values of 
4.9, 3.1 and 5 µM, respectively, without changing  IK1. Although the  EC50 value of CBD was found to be higher than liter-
ary  Cmax values after CBD smoking and oral intake, our results raise the possibility that potassium channel inhibition by 
lengthening cardiac repolarization might have a role in the possible proarrhythmic side effects of cannabinoids in situations 
where CBD metabolism and/or the repolarization reserve is impaired.
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Introduction
Cannabis has been one of the most abused hallucinogenic 
drugs since ancient times with an estimated 150 million 
consumers worldwide (Kalla et al. 2018). Moreover, the 
increasingly widespread use of e-cigarettes, the number of 
people inhaling cannabinoids might even be higher. In addi-
tion, the use of cannabis products for medicinal purposes is 
increasing globally. The enhanced general interest for the 
use of cannabis and cannabis-derived products was facili-
tated following the discovery of the cannabinoid system in 
humans (Sierra et al. 2018). The subsequent new findings 
on biological actions of cannabinoids on the central nervous 
system and immune functions attracted further attention. At 
present, there are cannabis-based drugs on the market with 
well-defined indications, including treatment of nausea and 
vomiting following chemotherapy, anorexia, pain related to 
cancer, spasticity and pain associated with multiple sclero-
sis, and Dravet and Lennox-Gastaut syndromes (Fraguas-
Sánchez and Torres-Suárez 2018). These drugs contain 
known amounts of CBD and/or THC in pure form or as 
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herbal extract (Fraguas-Sánchez and Torres-Suárez 2018). 
In addition to the use of CBD-containing products, CBD oil 
is very common with several, clinically unsupported indica-
tions. The consumption of cannabinoids, particularly CBD, 
which is enriched in numerous products, can be higher in 
case of the intake of CBD oils than in case of smoking can-
nabis. The consumption of cannabinoids, particularly CBD, 
which is enriched in numerous products, can be higher in 
case of the intake of CBD oils than in case of smoking can-
nabis. At high temperature, the majority of CBD is broken 
down (Czégény et al. 2021), whilst from CBD oils (in fact 
CBD dissolved in vegetable oils) containing up to 20% CBD, 
a significant amount of CBD is absorbed.
The possible cardiovascular side effects of cannabinoid 
use have been indicated in several reports, ranging from 
arrhythmias to myocardial infarction and even sudden car-
diac death (Pacher et al. 2018). According to a cohort study, 
marijuana smokers can have a 4.8-fold increase of risk devel-
oping acute myocardial infarction following the first hour 
of cannabinoid exposure (Mittleman et al. 2001). On the 
other hand, other reports do not support the link between 
cannabis use and cardiovascular events (Singh et al. 2019). 
Accordingly, an important comprehensive study assessed 
data for 316,397 cannabis users and 20,499,215 non-users 
found that cannabis use was an independent predictor of 
heart failure (Kalla et al. 2018). Although the mechanisms 
explaining these observations are poorly understood, the 
effects of cannabinoids exerted via the G protein-coupled 
cannabinoid receptors are suspected to play key roles. In 
addition, numerous studies reported proarrhythmic proper-
ties of cannabinoids including ventricular arrhythmias and 
even sudden cardiac death (Courts et al. 2016; Ozturk et al. 
2019; Manolis et al. 2019). However, the mechanism of 
these arrhythmias remains unclear (Ozturk et al. 2019). It 
was reported earlier and also recently that certain voltage-
gated ion channels like cardiac sodium, calcium (Al Kury 
et al. 2014), hERG and Kv4.3 channels (Amoros et al. 2010) 
might be also related to the reported cardiac effects of can-
nabinoids, but the possible effects of CBD on various car-
diac potassium currents which play a crucial role in car-
diac repolarization have not been studied yet in detail. Such 
transmembrane ion currents in cardiac ventricular muscle 
are the rapid  (IKr) and slow  (IKs) delayed rectifier potassium 
currents, the transient outward  (Ito) and inward rectifier  (IK1) 
potassium currents, all important for cardiac repolarization. 
Several cardiac and non-cardiac drugs are known to inhibit 
 IKr (also called hERG ion channel) and consequently they 
prolong cardiac QT interval and enhance dispersion of repo-
larization. The latter has been associated with the develop-
ment of life-threatening arrhythmias. Therefore, the official 
drug development procedure requires an early screening of 
whether a potential drug candidate has any activities on the 
hERG channels (Sanguinetti and Tristani-Firouzi 2006). 
However, drug effects on cardiac repolarization cannot be 
accurately estimated by measuring hERG channel and cur-
rents (Orvos et al. 2019), since drugs can also affect cardiac 
repolarization and action potential by acting on different cur-
rents other than hERG or  IKr.
Therefore, in the present study the aim was to investigate 
the effect of CBD, a major cannabinoid, on cardiac ventricu-
lar action potential and on several cardiac transmembrane 
currents to provide further experimental data for the elu-




All experiments were carried out in compliance with the 
Guide for the Care and Use of Laboratory Animals (USA 
NIH publication NO 85-23, revised 1996) and conformed to 
the Directive 2010/63/EU of the European Parliament. The 
protocols have been approved by the Ethical Committee for 
the Protection of Animals in Research of the University of 
Szeged, Szeged, Hungary (approval numbers: I-74-15-2017 
and I-74-24-2017) and by the Department of Animal Health 
and Food Control of the Ministry of Agriculture and Rural 
Development (authority approval numbers XIII/3330/2017 
and XIII/3331/2017).
Conventional microelectrode technique
Action potentials were recorded in right ventricular trabecu-
lar or papillary muscle preparations obtained from dog or 
rabbit hearts using conventional microelectrode techniques 
as described earlier in detail (Jost et al. 2013; Orvos et al. 
2019).
Preparations were individually mounted in a tissue cham-
ber with a volume of 50 ml. During experiments modified 
Locke’s solution was used, containing (in mM): NaCl 128.3, 
KCl 4,  CaCl2 1.8,  MgCl2 0.42,  NaHCO3 21.4 and glucose 
10. The pH of this solution was set between 7.35 and 7.4 
when gassed with the mixture of 95%  O2 and 5%  CO2 at 
37 °C. Each preparation was stimulated through a pair of 
platinum electrodes in contact with the preparation using 
rectangular current pulses of 1–3 ms duration at twice of 
the threshold strength at a constant basic cycle length of 
1000 ms for ventricular preparations. These stimuli were 
delivered for at least 60 min allowing the preparation to 
equilibrate before the measurements were initiated. Trans-
membrane potentials were recorded using conventional 
glass microelectrodes, filled with 3 M KCl and having tip 
resistances of 5–20 MΩ, connected to the input of a high 
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impedance electrometer (Experimetria, type 309, Budapest, 
Hungary) which was coupled to a dual beam oscilloscope.
The resting potential (RP), action potential amplitude 
(APA), maximum upstroke velocity  (Vmax) and APD meas-
ured at 50% and 90% of repolarization  (APD50 and  APD90, 
respectively) were determined off-line using an in-house 
developed software (APES) running on a computer equipped 
with an ADA 3300 analogue-to-digital data acquisition 
board (Real Time Devices, Inc., State College, Pennsylva-
nia) having a maximum sampling frequency of 40 kHz.
Attempts were made to maintain the same impalement 
throughout each experiment. In case an impalement became 
dislodged, adjustment was attempted, and if the action 
potential characteristics of the re-established impalement 
deviated by less than 5% from the previous measurement, 
the experiment continued.
Voltage‑clamp measurements
Ventricular myocytes were enzymatically dissociated from 
canine or rabbit hearts as described earlier in detail (Jost 
et al. 2013; Orvos et al. 2019). One drop of cell suspension 
was placed in a transparent recording chamber mounted on 
the stage of an inverted microscope (Olympus IX51, Olym-
pus, Tokyo, Japan), and individual myocytes were allowed to 
settle and adhere to the chamber bottom for at least 5–10 min 
before superfusion was initiated and maintained by grav-
ity. Only rod-shaped cells with clear striations were used. 
HEPES-buffered Tyrode’s solution (composition in mM: 
NaCl 144,  NaH2PO4 0.4, KCl 4.0,  CaCl2 1.8,  MgSO4 0.53, 
glucose 5.5 and HEPES 5.0, at pH of 7.4) served as the 
normal superfusate.
Micropipettes were fabricated from borosilicate glass 
capillaries (Science Products GmbH, Hofheim, Germany), 
using a P-97 Flaming/Brown micropipette puller (Sutter Co, 
Novato, CA, USA), and had a resistance of 1.5–2.5 MOhm 
when filled with pipette solution. The membrane currents 
were recorded with Axopatch-200B amplifiers (Molecular 
Devices, Sunnyvale, CA, USA) by means of the whole-cell 
configuration of the patch-clamp technique. The membrane 
currents were digitized with 250 kHz analogue-to-digital 
converters (Digidata 1440A, Molecular Devices, Sunnyvale, 
CA, USA) under software control (pClamp 10, Molecular 
Devices, Sunnyvale, CA, USA). Experiments were carried 
out at 37 °C.
Measurement of potassium currents
The inward rectifier  (IK1), transient outward  (Ito), rapid  (IKr) 
and slow  (IKs) delayed rectifier potassium currents were 
recorded in HEPES-buffered Tyrode’s solution. The com-
position of the pipette solution (in mM) was the follow-
ing: KOH 110, KCl 40,  K2ATP 5,  MgCl2 5, EGTA 5 and 
HEPES 10 (pH was adjusted to 7.2 by aspartic acid). 1 µM 
nisoldipine was added to the bath solution to block  ICaL. 
When  IKr was recorded  IKs was inhibited using the selective 
 IKs blocker HMR 1556 (0.5 µM). During  IKs measurements 
(a transmembrane current strongly depending from cAMP 
and protein kinase A, PKA; Christian et al. 2011),  IKr was 
blocked by 0.5 µM dofetilide and the bath solution contained 
0.1 µM forskolin.
Data analysis
All data are expressed as means ± SEM. The “n” number 
refers to the number of experiments (i.e. the number of cells 
in case of patch-clamp and the number of ventricular mus-
cle preparations—papillary or trabecular muscle—in case 
of action potential measurements). Statistical analysis was 
performed with Student’s t test for paired data. The results 
were considered statistically significant when P was < 0.05.
Results
The cardiac cellular electrophysiological effect of CBD 
was studied on various transmembrane ionic currents by 
the whole-cell configuration of the patch-clamp technique 
in native rabbit and dog ventricular myocytes and on action 
potentials in rabbit and dog ventricular papillary muscles 
by the conventional microelectrode technique. Figure 1 and 
Table 1 show that CBD lengthens action potential duration 
 (APD90) significantly at the concentration of 5 µM without 
changing other action potential parameters significantly.
Whole-cell patch-clamp experiments in rabbit cardiac 
ventricular myocytes revealed significant inhibition of the 
rapid delayed rectifier potassium current  (IKr) (Figs. 2A and 
3) with an estimated  EC50 value of 4.9 µM.  IKr was activated 
by 1000 ms long depolarizing voltage pulses with pulse fre-
quency of 0.05 Hz to the potentials ranging from − 30 mV 
to 50 mV and then the cell was repolarized to − 40 mV. The 
deactivating tail current at − 40 mV after the test pulse was 
assessed as  IKr. The holding potential was − 80 mV.
In similar experiments in rabbit myocytes CBD depressed 
the slow delayed rectifier potassium current  (IKs, Fig. 2B) 
with an estimated  EC50 value of 3.1 µM (Fig. 4), after 20 mV 
5 s long test pulse measured at − 40 mV.  IKs was recorded 
similarly to  IKr. After 5 s long depolarizing voltage pulses 
to various test potentials with pulse frequency of 0.1 Hz the 
cell was repolarized to − 40 mV and the tail current ampli-
tude was measured.
CBD even in the high concentration of 10 µM concentra-
tion did not influence the transient outward potassium current 
 (Ito) in rabbit (Fig. 5A) but decreased it significantly in dog 
(Fig. 5B) ventricular myocytes with an estimated  EC50 value 
of 5 µM (Fig. 6).  Ito was activated by 300 ms long depolarizing 
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voltage pulses arising from the holding potential of − 90 mV 
to test potentials gradually increasing up to 50 mV. The pulse 
frequency was 0.33 Hz.
As Fig. 7 indicates, CBD did not significantly change the 
inward rectifier potassium current  (IK1) even at the high, 10 µM 
concentration.  IK1 current was measured as the steady-state 
current level at the end of the 300 ms long voltage pulse in 
the voltage range of − 100 to 0 mV with a pulse frequency of 
0.33 Hz. The holding potential was − 90 mV.
Discussion
The main result of this study is that 5 µM CBD prolongs 
repolarization. This effect on repolarization in rabbit and 
dog papillary muscle can be best explained by the mul-
tiple effects CBD exerts on various potassium channels. 
Accordingly, as our previous results (Orvos et al. 2020) 
indicated, CBD administration at lower concentrations 
(1, 2.5 and 5 µM) resulted in hERG/IKr depression and 
a consequent lengthening of  APD90, but this effect was 
counterbalanced by the inhibition of inward  Ca2+ and  Na+ 
currents following CBD application at the high concentra-
tion of 10 µM. Similar effects were reported earlier with 
quinidine, an antiarrhythmic drug, with established proar-
rhythmic properties (Roden and Hoffman 1985; Varro 
et al. 1985).
A few previous studies with cannabinoids showed 
effects on various transmembrane ion channels such as 
inward sodium, (Al Kury et al. 2014; Ghovanloo et al. 
2018; Orvos et al. 2020) inward calcium (Al Kury et al. 
2014; Orvos et al. 2020), outward transient current (Li 
et al. 2012) and human Kv1.5 and Kv4.3 channels (Barana 
et al. 2010). In addition, in previous studies (Orvos et al. 
2020) hERG/IKr channel inhibition and QT prolongation 
were also reported in anaesthetized rats (Yun et al. 2016) 
and guinea pig (Orvos et al. 2020) by a synthetic can-
nabinoid compound (JWH-030) and CBD. This synthetic 
cannabinoid compound structurally differs from CBDs 
and inhibited hERG channels with a relatively high  EC50 
Fig. 1  Effect of CBD on the action potentials recorded from rabbit (panel A) and dog (panel B) papillary muscles. Dashed lines indicate zero 
mV levels
Table 1  Effect of acute exposure to CBD on the action potential 
parameters in rabbit and dog right ventricular papillary muscle prepa-
rations
Bold values are considered to be statistically significant (P < 0.05 
versus control)
P < 0.05 versus control
RP resting membrane potential, APA action potential amplitude, Vmax 
maximum upstroke velocity
APD50 and  APD90 action potential duration measured at 50 and 90% 
of repolarization




Control CBD 5 µM Control CBD 5 µM
RP (mV) − 84.1 ± 2.2 − 82.7 ± 1.7 − 84.7 ± 1.7 − 84.7 ± 2.3
APA (mV) 105.2 ± 3.0 106.4 ± 3.0 118.4 ± 3.3 120.4 ± 2.2
Vmax (V/s) 120.3 ± 20.6 113.0 ± 17.1 186.4 ± 21.7 201.0 ± 25.2
APD50 (ms) 171.8 ± 13.6 183.0 ± 12.8 178.3 ± 8.2 193.1 ± 4.5
APD90 (ms) 211.7 ± 11.2 224.6 ± 11.4 215.2 ± 9.0 231.7 ± 4.7
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(88.36 µM). Also, in rat ventricle hERG/IKr seems not 
as important for controlling repolarization as Kv4.2 and 
Kv1.5 channels. Therefore, the cannabinoid-evoked QT 
changes in rat most likely can be attributed to Kv1.5 and 
Kv4.2 rather than hERG channel inhibition. The finding 
of the present study that CBD inhibits  Ito in dog but not 
in rabbit ventricular myocytes are in good agreement with 
the previously mentioned rat study, since in dog  Ito is 
conducted Kv 4.3 (Han et al. 2002) but in rabbit by Kv 
1.4 channels (Wang et al. 1999). Since the APD measure-
ments in the present study were taken in subendocardial 
preparations, the latter effect on  Ito may result in more 
pronounced repolarization dispersion in dog and human 
ventricle where in midmyocardial cells  Ito is greater than 
in the subendocardium (Zicha et al. 2004).
According to human pharmacokinetic data, the  Cmax 
values for CBD can reach 0.35 µM and 0.58 µM during 
CBD smoking (19.2 mg) or following oral administration 
(400 mg), respectively (Millar et al. 2018). In the present 
experiments, CBD had inhibitory potency on both the 
hERG channel and  IKr activity, with an  EC50 value higher 
than literary  Cmax values in patients. This suggests small or 
negligible proarrhythmic risk in physiological conditions 
in healthy individuals. This is indeed in good agreement 
Fig. 2  Effect of CBD on the rapid  (IKr) and slow  (IKs) delayed rec-
tifier potassium currents. Panels show current–voltage curves for  IKr 
(panel A) and for  IKs (panel B) in control conditions and after appli-
cation of 5 µM CBD. Insets indicate the voltage protocols and origi-
nal  IKr and  IKS current records in control and in the presence of CBD. 
Data are expressed as means ± SEM
Fig. 3  Effect of CBD on the rapid  (IKr) delayed rectifier potassium 
currents. The panel displays CBD concentration–response curve indi-
cating an estimated  EC50 value of 4.9 µM for  IKr blockade. The insets 
show the tail current section of original  IKr current traces in control 
conditions and in the presence of 1  µM, 2.5  µM, 5  µM and 10  µM 
CBD recorded from rabbit left ventricular myocytes after a 1 s long 
pulse to 20 mV test potential with pulsing cycle length of 20  s.  IKr 
deactivating tail current was measured at -40 mV. The dashed lines 
refer to the baseline for  IKr tail current level after the test pulse at 
− 40 mV. Data are expressed as means ± SEM
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with clinical reports showing no significant  QTc prolon-
gation in patients after CBD administration (Sellers et al. 
2013). Also, in another clinical study, it was found that 
long term Sativex (THC + CBD) treatment evoked T wave 
changes in only 1 out of 146 patients (Serpell et al. 2013). 
Therefore, it is likely that in case of inhalation or oral use 
of cannabis-derived products, CBD itself may not represent 
a significant proarrhythmic risk. Based on the compari-
son of hERG or  IKr activity, cardiac action potential dura-
tion, and QT prolongation against QT effects and reports 
of arrhythmogenic (torsade de pointes) potential of 100 
drugs, a margin of 30-fold between hERG  EC50 and  Cmax 
was proposed to be an acceptable degree of safety regard-
ing arrhythmogenesis (Redfern et al. 2003). Taking into 
account the  EC50 values for  IKr,  IKs and  Ito inhibition in our 
experiments (4.9, 3.1 and 5 µM, respectively), the ratios of 
 EC50 and  Cmax values are in the range of about 8–9, which 
refers to moderately increased risk of arrhythmia. However, 
in patients who have considerably slower drug elimination 
due to certain concomitant diseases or in case of concur-
rent use of other drugs that inhibit the metabolism of CBD, 
higher  Cmax values can develop (Iffland and Grotenhermen 
Fig. 4  Effect of CBD on the slow  (IKs) delayed rectifier potassium 
currents. The panel displays CBD concentration–response curve indi-
cating an estimated  EC50 value of 3.1 µM for  IKs blockade. The insets 
show the tail current section of original  IKs current traces in control 
conditions and in the presence of 1  µM, 2.5  µM, 5  µM and 10  µM 
CBD recorded from rabbit left ventricular myocytes after a 5 s long 
pulse to 50 mV test potential with pulsing cycle length of 10  s.  IKs 
deactivating tail current was measured at -40 mV. The dashed lines 
refer to the baseline for  IKs tail current level after the test pulse at 
− 40 mV. Data are expressed as means ± SEM
Fig. 5  Effect of CBD on the transient outward potassium current  (Ito) 
in rabbit and dog ventricular myocytes. Panels show current–voltage 
curves for  Ito in control conditions and after application of CBD in 
rabbit (panel A) and in dog (panel B) ventricular myocytes. Insets 
indicate the voltage protocols and original  Ito current records in con-
trol and in the presence of CBD. Dashed lines indicate zero current 
levels. Data are expressed as means ± SEM
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2017), and this may further increase the risk for arrhythmia 
development.
Moreover, when CBD intake is combined with phar-
macological agents affecting cardiac repolarization, as 
well as in certain pathophysiological situations such as 
hypokalemia, or diseases like LQT syndrome, diabetes 
mellitus, HCM or heart failure where cardiac repolariza-
tion reserve (Varró and Baczkó 2011) or drug metabo-
lism is impaired, CBD can have an additive effect, fur-
ther increasing the proarrhythmic risk and the possible 
incidence of sudden cardiac death. Such additive interac-
tions were reported both in animal experimental (Lengyel 
et al. 2007) and clinical settings (Wisniowska et al. 2016). 
The cardiovascular effects of CBD may only partly be 
attributed to its effects on transmembrane ion channels, 
the cardiovascular safety of this compound may be influ-
enced by its activities on other targets, and by the pres-
ence of myocardial ischemia (Ferdinandy et al. 2019) as 
well. Therefore, further studies are needed to assess the 
unwanted cardiovascular effects of CBD and other can-
nabinoids both in vivo and in vitro studies, with special 
focus on the benefit-risk assessment of products with dif-
ferent cannabinoid content.
Fig. 6  Effect of CBD on the transient outward potassium current  (Ito) 
in dog ventricular myocytes. The panel displays CBD concentra-
tion–response curve indicating an estimated  EC50 value of 5 µM for 
 Ito blockade. Insets show original  Ito current traces in control condi-
tions and in the presence of 1 µM, 2.5 µM, 5 µM and 10 µM CBD 
recorded from dog left ventricular myocytes after a 300 ms long pulse 
to 50 mV test potential with pulsing cycle length of 3 s. The inset on 
right-bottom displays original  Ito current traces in control conditions 
and in the presence of the solvent (0.1% DMSO). Dashed lines indi-
cate zero current levels. Data are expressed as means ± SEM
Fig. 7  Lack of effect of CBD on 
the inward rectifier potassium 
current in rabbit left ventricular 
myocytes. The panel shows 
steady-state current–volt-
age curves for  IK1 in control 
conditions and after application 
of 10 µM CBD in rabbit left 
ventricular myocytes. Inset indi-
cates the voltage protocol. Data 
are expressed as means ± SEM
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